Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey †

Author: Shiozawa Tomoo   Tadokoro Jun-ichi   Fujiki Toshitaka   Fujino Koji   Kakihata Koji   Masatani Shuji   Morita Satoshi   Gemma Akihiko   Boku Narikazu  

Publisher: Oxford University Press

ISSN: 1465-3621

Source: Japanese Journal of Clinical Oncology, Vol.43, Iss.5, 2013-05, pp. : 483-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content